Belçika - İngilizce - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva b.v. - paliperidone 9 mg - prolonged-release tablet - 9 mg - paliperidone 9 mg - paliperidone

Belçika - İngilizce - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva b.v. - paliperidone 3 mg - prolonged-release tablet - 3 mg - paliperidone 3 mg - paliperidone

Belçika - İngilizce - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva b.v. - paliperidone 6 mg - prolonged-release tablet - 6 mg - paliperidone 6 mg - paliperidone

Singapur - İngilizce - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - paliperidone palmitate 156 mg eqv paliperidone - injection, suspension, extended release - 100mg/1ml - paliperidone palmitate 156 mg eqv paliperidone 100mg/1ml

Singapur - İngilizce - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - paliperidone palmitate 234 mg eqv paliperidone - injection, suspension, extended release - 150mg/1.5ml - paliperidone palmitate 234 mg eqv paliperidone 150mg/1.5ml

Singapur - İngilizce - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - paliperidone palmitate 39 mg eqv paliperidone - injection, suspension, extended release - 25mg/0.25ml - paliperidone palmitate 39 mg eqv paliperidone 25mg/0.25ml

Singapur - İngilizce - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - paliperidone palmitate 78 mg eqv paliperidone - injection, suspension, extended release - 50mg/0.5ml - paliperidone palmitate 78 mg eqv paliperidone 50mg/0.5ml

Singapur - İngilizce - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - paliperidone palmitate 117 mg eqv paliperidone - injection, suspension, extended release - 75mg/0.75ml - paliperidone palmitate 117 mg eqv paliperidone 75mg/0.75ml

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - paliperidone, quantity: 9 mg - tablet, modified release - excipient ingredients: sodium chloride; iron oxide red; purified water; hyetellose; macrogol 3350; carnauba wax; butylated hydroxytoluene; polyethylene oxide; povidone; stearic acid; isopropyl alcohol; propylene glycol; iron oxide black; hypromellose; titanium dioxide; macrogol 400; cellulose acetate - invega is indicated for the treatment of schizophrenia, including acute treatment and recurrence prevention. invega is indicated for the treatment of acute exacerbations of schizoaffective disorder as monotherapy and in combination with antidepressants and/or mood stabilizers (lithium and valproate).

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - paliperidone, quantity: 6 mg - tablet, modified release - excipient ingredients: butylated hydroxytoluene; sodium chloride; povidone; stearic acid; polyethylene oxide; iron oxide red; hyetellose; macrogol 3350; macrogol 400; carnauba wax; isopropyl alcohol; propylene glycol; cellulose acetate; titanium dioxide; hypromellose; purified water; iron oxide black; iron oxide yellow - invega is indicated for the treatment of schizophrenia, including acute treatment and recurrence prevention. invega is indicated for the treatment of acute exacerbations of schizoaffective disorder as monotherapy and in combination with antidepressants and/or mood stabilizers (lithium and valproate).